Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study

Abstract

What is this summary about?

This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.

Keywords

asthma randomized clinical trial rescue therapy severe exacerbations efficacy safety

Click here to view the PDF

Footnotes

Acknowledgements

AstraZeneca and Avillion would like to thank the clinical study participants and their family members and carers. They would also like to thank the investigators and staff at the study centers who cared for the participants in the clinical studies.

Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study

Abstract

Keywords

Footnotes

Acknowledgements

Declarations